Clover Health Investments, Corp.

CLOV Healthcare Healthcare Plans

Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.

Revenue
+52.9%
EPS
+350.0%
Free cash flow
+508.9%

Quarter to September 2026, against a year earlier

4.82 0.34 +7.59%
Market cap
$2.4B
P/E
0.0×
Fwd P/E
87.4×
Dividend yield
—
F-score
3/9
Altman Z
0.44
Beneish M
−1.72
Dividend safety
n/a

Clover Health Investments, Corp. (CLOV) P/E ratio

Alert me on P/E ratio

Clover Health Investments, Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
23 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
CLOV Clover Health Investments, Corp. n/m
MOH Molina Healthcare, Inc compare n/m
OSCR Oscar Health, Inc. compare 11.0×
CI Cigna Group compare 12.9×
ELV Elevance Health, Inc. compare 18.2×
CNC Centene Corporation compare 23.5×
PGNY Progyny, Inc. compare 30.1×
HUM Humana Inc. compare 41.9×
ALHC Alignment Healthcare, Inc. compare 48.4×
Healthcare Plans industry median 22.5×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on CLOV